We care for
Biokinetica GmbH is a clinical research company equipped with its own Clinical Pharmacology Unit, headquartered in Berlin with an operational hub in Warsaw.
We specialize in conducting various Early Phase studies, including First in Human (FiH), Biosimilars, Proof of Concept, and other Clinical Pharmacology trials with Healthy Volunteers and Patients. Known globally, Biokinetica is recognized as an expert in conducting time- and cost-effective large Phase I Biosimilar projects with healthy volunteers.
As a reference Phase One Unit and preferred vendor, we are trusted by the world’s leading global CROs, and Pharma & Biotech companies.
Our clinical trials are conducted at our FDA-inspected, hospital-based, state-of-the-art Phase One Unit, located in the Warsaw area, Poland. The 50-bed hospital unit is located adjacent to a specialized cardiology hospital, a 5-minute drive from a general hospital, and 25 minutes from Warsaw Airport and downtown Warsaw.
Due to its excellent location adjacent to the metro station and well-orchestrated organization, the clinic boasts a throughput exceeding 150 volunteers screened daily, including over weekends.
With a cadre of over 70 highly qualified study staff, each boasting an average clinical trial experience of 5 years, we present a robust team comprising:
Our specialized teams are dedicated to conducting early-phase studies with both healthy volunteers and patient populations across a diverse range of therapeutic areas.